Insider Transactions in Q1 2022 at Verve Therapeutics, Inc. (VERV)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,674
+12.73%
|
$139,348
$2.87 P/Share
|
|
Mar 15
2022
|
Burt A Adelman |
BUY
Open market or private purchase
|
Indirect |
4,000
+31.5%
|
$84,000
$21.38 P/Share
|
|
Mar 09
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,971
-0.48%
|
$115,159
$29.01 P/Share
|
|
Feb 09
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,190
-1.56%
|
$382,510
$29.46 P/Share
|
|
Feb 01
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,574
-4.05%
|
$1,031,646
$29.04 P/Share
|
|
Jan 27
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,983
-0.51%
|
$260,507
$29.64 P/Share
|
|
Jan 26
2022
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
149,853
-5.02%
|
$4,495,590
$30.92 P/Share
|
|
Jan 04
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,870
-0.46%
|
$72,930
$39.9 P/Share
|
|
Jan 04
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,870
+0.46%
|
$1,870
$1.39 P/Share
|